Refine by
Applications
- Flagship Coil for Major Depressive Disorder (MDD) Treatment
- Flagship Coil for Anxious Depression Treatment
- Flagship Coil for Obsessive-Compulsive Disorder (OCD) Treatment
- Flagship Coil for Smoking Addiction Treatment
- Flagship Coil for Bipolar Disorder Treatment
- Flagship Coil for Post Traumatic Stress Disorder Treatment Treatment
- Flagship Coil for Schizophrenia (Negative Symptoms) Treatment
- Flagship Coil for Alzheimer’s Disease Treatment
- Flagship Coil for Autism Disorder Treatment Technology
Depressive Episode Equipment & Supplies
3 equipment items found
by:Italfarmaco SpA based inMilan, ITALY
Zarelis: (Venlafaxine 37.5, 75, 150 and 225mg tablets) indicated in the treatment of major depressive episodes, prevention of recurrences of major depressive episodes, treatment of social anxiety disorder. The peculiar characteristics of Zarelis are the innovative formulation in osmotic sustained-release tablets and the ...
by:Italfarmaco SpA based inMilan, ITALY
Dropaxin: (paroxetine hydrochloride – oral drops, 10 mg/ml solution) the first paroxetine hydrochloride available in oral drops; indicated in the treatment of major depressive episodes, obsessive-compulsive disorders, panic disorders both with and without agoraphobia, social anxiety disorder / social phobia, generalized anxiety disorder, post-traumatic ...
Manufactured by:BrainsWay Ltd. based inBurlington, MASSACHUSETTS (USA)
BrainsWay’s treatment was cleared by the FDA in 2013 for patients who tried any number of antidepressants with no improvement in the current depressive episode. The FDA indication is based on a unique 16-week double-blind, placebo-controlled, multi-center study which enrolled over 200 subjects, and reported a marked decline in HDRS-21 scores, as well as ...